Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen?
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Pantosti (Rome, Italy). Mechanisms of acquisition of resistance in Staphylococcus aureus. Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen?

Member's Comments

No comment yet.

Related content which might interest you: Treatment challenges in methicillin resistant Staphylococcus aureus infections Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Cell wall deficiency: a novel mechanism for methicillin resistance in Staphylococcus aureus Source: Eur Respir J 2005; 26: Suppl. 49, 94s Year: 2005 Staphlococcus aureus: susceptibility to antibacterial drugs and rate of MRSA Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006 Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 What is MRSA? Source: Eur Respir J 2009; 34: 1190-1196 Year: 2009 Evolution of tetracycline resistant S. aureus in hypoxia Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection Source: Eur Respir J 2002; 20: Suppl. 38, 357s Year: 2002 Staphylococcus aureus sensitivity changes to antibiotics under the influence of dissolved ozone Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 Changes in susceptibility to antibiotics staphylococcus aureus under effect of dissolved ozone Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant staphylococcus aureus (CA-MRSA) Source: Eur Respir J 2007; 30: Suppl. 51, 407s Year: 2007 Molecular epidemiology and antimicrobial resistance of methicillin-resistant staphylococcus aureus isolated from nasal swab at intensive care unit Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008 Community-associated methicillin-resistant staphylococcus aureus (CA-MRSA) as a cause of hospital-acquired pneumonia (HAP) Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007 CusS-cusR mediate carbapenem-resistant Klebsiella pneumoniae resistant to tigecycline. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 The antimicrobial molecule elafin protects the lung against Staphylococcus aureus infection Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae Source: Eur Respir J 2006; 27: 1020-1025 Year: 2006 Exposure to sub-lethal levels of penicillin G and high osmotic potential leads to stable antibiotic resistance in Staphylococcus aureus Source: Eur Respir J 2002; 20: Suppl. 38, 421s Year: 2002 Detection of alpha-hemolysin in Staphylococcus aureus derived respiratory strains: correlation with microbiological and clinical variables Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial Source: Eur Respir J 2004; 23: 921-926 Year: 2004